Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
The European Molecular Biology Laboratory (EMBL) has done it again—they have developed another database of which they can be “proud.” PRIDE is quite literally the name of the game when it comes to this proteomics database, whose full name is the PRoteomics IDEntifications database. Containing more proteomics data than a single person could ever sort through in his/her entire career, the PRIDE database houses over 16,000 experiments, over 145 million (yes, million!) MS spectra, and more than 24 million identified peptides. Users of the database can either search its contents or browse by a number of categories, such as species, cell type, or disease. Additionally, the site recently made the PRIDE Inspector available for download. This application allows one to browse, visualize, and analyze MS proteomics data. This database is a fantastic resource for proteomics researchers.